Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy;Współczesne pogla̧dy na temat roli dehydroepiandrosteronu w fizjologii, patologii i terapii

Polski Merkuriusz Lekarski

Volumn 24, Issue 139, 2008, Pages 66-71

  Krysiak, Robert ^a,c,e   Frysz Naglak, Dorota ^b,d   Okopień, BogusŁaw ^a,c  

^a Klinika Chorób Wewn trznych i Farmakologii Klinicznej Katedry Farmakologii

^b Oddziat Chorob Wewnȩtrznych W Katowicach ^*

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d Hospital of the Ministry of Interior Affairs and Administration   (Poland)

^e Klinika Chorób Wewn trznych i Farmakologii Klinicznej   (Poland)

Author keywords

Adrenal insufficiency; Adrenopause; Dehydroepiandrosterone (DHEA); Efficiency; Safety; Therapeutic appliance

Indexed keywords

DEHYDROEPIANDROSTERONE RECEPTOR; PRASTERONE; STEROID RECEPTOR;

ADRENAL DISEASE; ADRENAL GLAND; ADRENARCHE; AGED; AGING; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; DEMENTIA; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL GLAND DISEASES; ADRENAL GLANDS; ADRENARCHE; AGED; AGING; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; DEHYDROEPIANDROSTERONE; DEMENTIA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECEPTORS, STEROID;

EID: 39049118804     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Achermann J.C., Silverman B.L.: Dehydroepiandrosterone replacement for patients with adrenal insufficiency. Lancet, 2001, 357, 1381-1382.
2. Alesci S., Bornstein S.R.: Intraadrenal mechanisms of DHEA regulation: a hypothesis for adrenopause. Exp. Clin. Endocrinol. Diabetes, 2001, 109, 75-82.
3. Alesci S., Koch CA., Bornstein S.R. i wsp.: Adrenal androgens regulation and adrenopause. Endocr. Regul., 2001, 35, 95-100.
4. Alesci S., Manoli I., Blackman M.R.: Dehydroepiandrosterone (DHEA). In: Encyclopedia of Dietary Supplements (ed. Coates P.). Marcel Dekker. New York, USA, 2005, 167-174.
5. Allolio B., Arlt W.: DHEA treatment: myth or reality? Trends Endocrinol. Metab., 2002, 13, 288-294.
6. Anisimov V.N.: Premature ageing prevention: limitations and perspectives of pharmacological interventions. Curr. Drug Targets, 2006, 7, 1485-1503.
7. Arlt W.: Dehydroepiandrosterone replacement therapy. Curr. Opin. Endocrinol. Diab., 2006, 13, 291-305.
8. Auchus RJ.: Overview of dehydroepiandrosterone biosynthesis. Semin. Reprod. Med., 2004, 22, 281-288.
9. Auchus RJ., Rainey W.E.: Adrenarche - physiology, biochemistry and human disease. Clin. Endocrinol. (Oxf.), 2004, 60, 288-296.
10. Baulieu E.E.: Androgens and aging men. Mol. Cell. Endocrinol., 2002, 198, 41-49.
11. Berr C., Lafont S., Debuire B. i wsp.: Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc. Natl. Acad. Sci. USA, 1996, 93, 13410-13415.
12. Binello E., Gordon C.M.: Clinical uses and misuses of dehydroepiandrosterone. Curr. Opin. Pharmacol., 2003, 3, 635-641.
13. Buvat J.: Androgen therapy with dehydroepiandrosterone. World J. Urol., 2003, 21, 346-355.
14. Cameron D.R., Braunstein G.D.: The use of dehydroepiandrosterone therapy in clinical practice. Treat. Endocrinol., 2005, 4, 95-114.
15. Celec P., Starka L.: Dehydroepiandrosterone - is the fountain of youth drying out? Physiol. Res., 2003, 52, 397-407.
16. Davison S.L., Bell R.: Androgen physiology. Semin. Reprod. Med., 2006, 24, 71-77.
17. Dharia S., Parker CR. Jr.: Adrenal androgens and aging. Semin. Reprod. Med., 2004, 22, 361-368.
18. Dillon J.S.: Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr. Drug Targets lnflamm. Allergy, 2005, 4, 377-385.
19. Ferrari E., Cravello L., Muzzoni B. i wsp.: Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur. J. Endocrinol., 2001, 144, 319-329.
20. Gordon C.M., Glowacki J., LeBoff M.S.: DHEA and the skeleton (through the ages). Endocrine, 1999, 11, 1-11.
21. Greendale G.A., Edelstein S., Barrett-Connor E.: Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J. Bone Miner. Res., 1997, 12, 1833-1843.
22. Gurnell E.M., Chatterjee V.K.: Dehydroepiandrosterone replacement therapy. Eur. J. Endocrinol., 2001, 145, 103-106.
23. Harper A.J., Buster J.E., Casson P.R.: Changes in adrenocortical function with aging and therapeutic implications. Semin. Reprod. Endocrinol., 1999, 17, 327-338.
24. Hinson J.P., Raven P.W.: DHEA deficiency syndrome: a new term for old age? J. Endocrinol., 1999, 163, 1-5.
25. Hinson J.P., Brooke A., Raven P.W.: Therapeutic uses of dehydroepiandrosterone. Curr. Opin. Investig. Drugs, 2003, 4, 1205-1208.
26. Hornsby P.J.: Aging of the human adrenal cortex. Ageing Res. Rev., 2002, 1, 229-242.
27. Johnson M.D., Bebb R.A., Sirrs S.M.: Uses of DHEA in aging and other disease states. Ageing Res. Rev., 2002, 1, 29-41.
28. Labrie F.: Adrenal androgens and intracrinology. Semin. Reprod. Med., 2004, 22, 299-309.
29. Leowattana W.: DHEA(S): the fountain of youth. J. Med. Assoc. Thai, 2001, 84, suppl. 2, S605-S612.
30. Nawata H., Yanase T., Goto K. i wsp.: Adrenopause. Horm. Res., 2004, 62, suppl. 3, 110-114.
31. Racchi M., Balduzzi C., Corsini E.: Dehydroepiandrosterone (DHEA) and the aging brain: flipping a coin in the "fountain of youth". CNS Drug. Rev., 2003, 9, 21-40.
32. Saltzman E., Guay A.: Dehydroepiandrosterone therapy as female androgen replacement. Semin. Reprod. Med., 2006, 24, 97-105.
33. Schwartz A.G., Pashko L.L.: Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity. Ageing Res. Rev., 2004, 3, 171-187.
34. Shifren J.L.: The role of androgens in female sexual dysfunction. Mayo Clin. Proc., 2004, 79, 4 suppl. S19-S24.
35. Szathmari M., Szucs J., Feher T. i wsp.: Dehydroepiandrosterone sulphate and bone mineral density. Osteoporos. Int., 1994, 4, 84-88.
36. Tchemof A., Labrie F.: Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur. J. Endocrinol., 2004, 151, 1-14.
37. Villareal D.T.: Effects of dehydroepiandrosterone on bone mineral density: what implications for therapy? Treat. Endocrinol., 2002, 1, 349-357.
38. Yen S.S.: Dehydroepiandrosterone sulfate and longevity: new clues for an old friend. Proc. Natl. Acad. Sci. USA, 2001, 98, 8167-8169.